ChanTest to Showcase New Ion Channel & GPCR Assays for Drug Discovery at SBS 2010

06 Apr 2010
Share
The Ion Channel Experts at ChanTest will be highlighting their industry-leading collection of Ion Channel products and services for screening and profiling. ChanTest Scientists will also be presenting Sodium Channel Screening for Drug Discovery (poster #H810) in the Ion Channels and Transporters in Drug Discovery session.

The company’s product and service portfolio also includes an extensive offering of over 200 GPCR assays for research and Drug Discovery, including 70 new GPCR cell lines that utilize co-expressed Cyclic Nucleotide-Gated (CNG) channels to detect G-protein-induced changes in intracellular cAMP levels via changes in membrane potential.

To find out more visit booth 322.

Request Info


Company website

ChanTest Corporation